Viking Therapeutics Inc. (VKTX)
Market Closed
16 Oct, 08:00 PM
$
25. 17
-2.2
-8.038%
$
3.48B Market Cap
- P/E Ratio
- Div Yield
7.57M Volume
-0.92 Eps
$ 27.37
Previous Close 
Want to track VKTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Viking Therapeutics Inc. (VKTX) Statistics
Valuation metrics
Market Cap 3.48B
Enterprise value 3.08B
Trailing P/E (ttm) -5.4
Forward P/E -7.58
PEG ratio 0.07
Price/Sales (ttm) -
Price/Book (mrq) 7.15
Enterprise Value/Revenue -
Enterprise Value/EBITDA -5.76
Overview
Shares outstanding 114.79M
Float 112.74M
Shares short 24.01M
% Held by insiders 0.03%
% Held by institutions 0.63%
Average volume (10 days) 5.77M
Average volume (90 days) 4.48M
Price summary
52-Week low 24.94
52-Week high 43.15
Beta 0.82
50-Day moving average 31.4
200-Day moving average 33.01
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.02%
Return on equity -0.95%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -359.64M
Diluted EPS (ttm) -4.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 705.74M
Total cash per share (mrq) 4.33
Total debt (mrq) 137K
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.72%
Book value per share (mrq) 3.52
Cash Flow
Cash flow statement -278.68M
Levered free cash flow (LFCF) -160.22M
2026 © Marketlog. All Rights Reserved.
